Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,500 | 29,930 | 31,750 | 34,830 | 36,250 |
| Receivables | 390 | 300 | 190 | 550 | 490 |
| Other current assets | 440 | 650 | 790 | 310 | 540 |
| TOTAL | $28,330 | $30,880 | $32,730 | $35,690 | $37,280 |
| Non-Current Assets | |||||
| PPE Net | 370 | 370 | 370 | 410 | 430 |
| Other Non-Current Assets | 80 | 80 | 80 | 80 | 80 |
| TOTAL | $450 | $450 | $450 | $490 | $510 |
| Total Assets | $28,580 | $31,150 | $33,010 | $36,000 | $37,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,370 | 2,790 | 2,170 | 4,320 | 2,170 |
| Other current liabilities | 20 | 20 | 650 | 50 | 70 |
| TOTAL | $2,390 | $2,820 | $2,820 | $4,370 | $2,240 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,390 | $2,820 | $2,820 | $4,370 | $2,240 |
| Shareholders' Equity | |||||
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -41,260 | -38,810 | -36,960 | -33,540 | -30,140 |
| Other shareholders' equity | -1,390 | -1,520 | -1,660 | 130 | 240 |
| TOTAL | $26,190 | $28,330 | $30,190 | $31,630 | $35,390 |
| Total Liabilities And Equity | $28,580 | $31,150 | $33,010 | $36,000 | $37,630 |